Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


10th week of 2020 patent applcation highlights part 26
Patent application numberTitlePublished
20200071276Acridine Compound for Use in an Electronic Device and Display Device2020-03-05
20200071277PHOTOREACTIVE LIGANDS AND USES THEREOF2020-03-05
20200071278PROCESS FOR THE PREPARATION OF 2-CYANOIMIDAZOLE COMPOUNDS2020-03-05
20200071279DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF2020-03-05
20200071280PYRIMIDINE DERIVATIVE2020-03-05
202000712811,4,5-SUBSTITUTED 1,2,3-TRIAZOLE ANALOGUES AS ANTAGONISTS OF THE PREGNANE X RECEPTOR2020-03-05
20200071282FXR (NR1H4) MODULATING COMPOUNDS2020-03-05
20200071283COMPOUND CONTAINING BASIC DYE AND AMINO ACID, HAIR DYING DYE, AND HAIR DYING COMPOSITION2020-03-05
20200071284ANTIFUNGAL COMPOUNDS DERIVED FROM LAVENDER OIL2020-03-05
20200071285CONTINUOUS ISOLATION OF CANNABIDIOL AND CONVERSION OF CANNABIDIOL TO DELTA 8-TETRAHYDROCANNABINOL AND DELTA 9-TETRAHYDROCANNABINOL2020-03-05
20200071286UTILIZATION OF NORMAL CARBON 4 (NC4) RECYCLE STREAM FOR SECONDARY AND TERTIARY PRODUCTS2020-03-05
20200071287PROCESS FOR PREPARATION OF APALUTAMIDE2020-03-05
20200071288SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE2020-03-05
20200071289SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME2020-03-05
20200071290Pyrazole Amine Reactive Crystallization2020-03-05
20200071291A CLASS OF ISOINDOLONE-IMIDE RING-1,3-DIONE-2-ENE COMPOUNDS, COMPOSITION AND USE THEREOF2020-03-05
20200071292SUBSTITUTED QUINAZOLINE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY2020-03-05
20200071293NEW CRYSTALLINE FROM OF ARIPIPRAZOLE2020-03-05
20200071294ISOQUINOLINE COMPOUNDS, METHODS FOR THEIR PREPARATION, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA GALACTOSIDASE2020-03-05
20200071295METHOD FOR PRODUCING BENZIMIDAZOLE DERIVATIVE2020-03-05
20200071296Compounds and Methods of Use2020-03-05
20200071297NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS2020-03-05
20200071298COMPOUNDS AS MODULATORS OF ROR GAMMA2020-03-05
20200071299POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS2020-03-05
20200071300Small Molecule Stimulators of Steroid Receptor Coactivator-3 and Methods of Their Use as Cardioprotective and/or Vascular Regenerative Agents2020-03-05
20200071301Aryi, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders2020-03-05
20200071302N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF2020-03-05
20200071303DIPHENYLAMINOPYRIMIDINE COMPOUND FOR INHIBITING KINASE ACTIVITY2020-03-05
20200071304SELECTIVE NR2B ANTAGONISTS2020-03-05
20200071305BIARYL PIPERIDINE AMIDE COMPOUNDS AND METHODS OF USE THEREOF2020-03-05
20200071306Combinations For Treatment Of NASH/NAFLD And Related Diseases2020-03-05
20200071307SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY IN ANIMALS2020-03-05
20200071308Benzene, Pyridine, and Pyridazine Derivatives2020-03-05
20200071309INHIBITORS OF MUTANT ISOCITRATE DEHYDROGENASES AND COMPOSITIONS AND METHODS THEREOF2020-03-05
20200071310N-ARYL PYRAZOLES AS NRF2 REGULATORS2020-03-05
20200071311CHEMICAL COMPOUNDS2020-03-05
20200071312BENZIMIDAZOLE COMPOUNDS AND USE THEREOF FOR TREATING ALZHEIMER'S DISEASE OR HUNTINGTON'S DISEASE2020-03-05
20200071313HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS2020-03-05
20200071314Novel Aminothiazole Compounds and Methods Using Same2020-03-05
20200071315AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES2020-03-05
20200071316ACTIVATORS OF THE RETINOIC ACID INDUCIBLE GENE "RIG-I" PATHWAY AND METHODS OF USE THEREOF2020-03-05
20200071317ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS2020-03-05
20200071318SGC STIMULATORS2020-03-05
202000713194,5-DISUBSTITUTED-1H-PYRROLO(2,3-F)QUINOLIN-2,7,9-TRICARBOXYLATE COMPOUND AND USE THEREOF2020-03-05
20200071320FUSED HETEROCYCLIC COMPOUND AND COMPOSITION CONTAINING SAME2020-03-05
20200071321METHODS AND USES OF COMPOUNDS FOR TREATING DISEASE2020-03-05
20200071322INHIBITING (ALPHA-V)(BETA-6) INTEGRIN2020-03-05
20200071323DIMETHYL AMINO AZETIDINE AMIDES AS JAK INHIBITORS2020-03-05
20200071324PROCESS FOR PREPARING JAK INHIBITORS AND INTERMEDIATES THEREOF2020-03-05
202000713255 TO 7 MEMBERED HETEROCYCLIC AMIDES AS JAK INHIBITORS2020-03-05
20200071326TAM KINASE INHIBITORS2020-03-05
20200071327Prodrugs for the Treatment of Disease2020-03-05
202000713281,6- DIAZABICYCLO [3,2,1] OCTAN-7-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS2020-03-05
20200071329BCL-2 INHIBITORS2020-03-05
20200071330THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS2020-03-05
202000713312,6-DIAMINO PYRIDINE COMPOUNDS2020-03-05
20200071332BROMODOMAIN INHIBITORS2020-03-05
20200071333PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES2020-03-05
20200071334PYRROLOPYRIMIDINE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY2020-03-05
20200071335CRYSTALLINE FORMS OF A PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITOR2020-03-05
20200071336COMPOUND OF EOC315 MOD.I CRYSTAL FORM AND PREPARATION METHOD THEREOF2020-03-05
20200071337ANTIVIRAL COMPOUNDS2020-03-05
20200071338CAVITAND COMPOSITIONS AND METHODS OF USE THEREOF2020-03-05
20200071339OXYGEN LINKED PYRIMIDINE DERIVATIVES2020-03-05
20200071340PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS2020-03-05
20200071341PREPARATION OF A SOLID FORM OF GADOBENATE DIMEGLUMINE2020-03-05
20200071342VOLTAGE SENSITIVE DYES2020-03-05
20200071343ORGANIC SEMICONDUCTING MATERIAL AND ITS SYNTHESIS AND ORGANIC SEMICONDUCTING COMPONENT WITH THE MATERIAL2020-03-05
20200071344METHODS FOR MAKING QUINOLINYLDIAMINES2020-03-05
20200071345Bridged Phenolate Transition Metal Complexes, Production, and uses Thereof2020-03-05
20200071346ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND2020-03-05
20200071347METHOD FOR PRODUCING TRANSITION METAL-ISOCYANIDE COMPLEX2020-03-05
20200071348PROCESS FOR PRODUCING ISOPROPYLIDENE BIS(CYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE2020-03-05
20200071349Metallocene Compounds Having Appended Lewis Acids and Polymerization Therewith2020-03-05
20200071350SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR2020-03-05
20200071351TACCALONOLIDE MICROTUBULE STABILIZERS2020-03-05
20200071352STABILIZED ANTIBODY PROTEIN SOLUTIONS2020-03-05
20200071353Separation Matrix2020-03-05
20200071354PEPTIDOMIMETICS FOR THE TREATMENT OF NOROVIRUS INFECTION2020-03-05
20200071355THERAPEUTIC PEPTIDES2020-03-05
20200071356COMPOUNDS FOR PROTEASOME2020-03-05
20200071357ANTIMICROBIAL PEPTIDES2020-03-05
20200071358BIOCIDAL PEPTIDE AND PREPARATION BASED THEREON2020-03-05
20200071359PERIPHERAL MODIFICATIONS ON POCKET-REDESIGNED VANCOMYCIN ANALOGS SYNERGISTICALLY IMPROVE ANTIMICROBIAL POTENCY AND DURABILITY2020-03-05
20200071360TAILORED CYCLODEPSIPEPTIDES AS POTENT NON-COVALENT SERINE PROTEASE INHIBITORS2020-03-05
20200071361ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE2020-03-05
20200071362SYNTHETIC PROTEIN CIRCUITS DETECTING SIGNAL TRANSDUCER ACTIVITY2020-03-05
20200071363ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD2020-03-05
20200071364CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF2020-03-05
20200071365Mycobacteria Tuberculosis Chaperonin 60.1 Peptides and Uses Thereof2020-03-05
20200071366POWDERED WHEAT PROTEIN AND METHOD FOR PRODUCING SAME2020-03-05
20200071367A NOVEL NERVOUS SYSTEM-SPECIFIC TRANSMEMBRANE PROTEASOME COMPLEX THAT MODULATES NEURONAL SIGNALING THROUGH EXTRACELLULAR SIGNALING VIA BRAIN ACTIVITY PEPTIDES2020-03-05
20200071368SPLIT INTEIN MEDIATED POLYMERIZATION AND PRODUCTION OF MUSSEL FOOT ADHESIVE PROTEIN MATERIALS2020-03-05
20200071369TARGETED DNA DEMETHYLATION AND METHYLATION2020-03-05
20200071370CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION2020-03-05
20200071371IL-1RA CDNAS2020-03-05
20200071372C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof2020-03-05
20200071373NATIVE CELL DERIVED VESICLES CONTAINING TUMOR SUPPRESSOR PROTEINS FOR THERAPY2020-03-05
20200071374MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF2020-03-05
20200071375TYPE I AND TYPE III INTERFERON FUSION MOLECULES AND METHODS FOR USE THEREOF2020-03-05
Website © 2025 Advameg, Inc.